Patent Assignment
Reel/Frame 036947/0373
Assignment of Assignor's Interest
Recorded: 2015-11-03
Pages: 7
Assignors
LIU, SHUANG
Executed: 2013-01-09
DUFFY, BRYAN CORDELL
Executed: 2013-01-09
JIANG, MAY XIAOWU
Executed: 2013-01-09
WANG, RUIFANG
Executed: 2013-01-11
QUINN, JOHN FREDERICK
Executed: 2013-01-09
MARTIN, GREGORY SCOTT
Executed: 2013-01-09
ZHAO, HE
Executed: 2013-01-09
MOLINO, BRUCE FRANCIS
Executed: 2013-01-09
YOUNG, PETER RONALD
Executed: 2013-01-17
Assignee
RESVERLOGIX CORP.
202,279 MIDPARK WAY SE, CALGARY, AB, T2X 1M2, CANADA
Covered Property
(1)
Novel Heterocyclic Compounds as Bromodomain Inhibitors
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
General Conveyance and Assumption Agreement
Jul 14, 2014
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 033312/0422 →
Assignment of Assignor's Interest
Nov 3, 2015
From: RESVERLOGIX CORP.
To: RVX THERAPEUTICS INC.
Reel/Frame 036947/0382 →
Change of Name
Dec 21, 2016
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 041120/0548 →
Assignment of Assignor's Interest
Dec 23, 2016
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 041182/0891 →